Involvement of MT1-MMP and TIMP-2 in human periodontal disease

Oral Diseases

Volumn 16, Issue 4, 2010, Pages 388-395

  Oyarzun A ^a   Arancibia, R ^b   Hidalgo, R ^c   Penafiel C ^c   Caceres M ^a   Gonzalez M J ^c   Martinez J ^c   Smith, P C ^b  

^a UNIVERSIDAD FINIS TERRAE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

MMP; MMP 14; MT1 MMP; Periodontal disease; TIMP 2

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CELL TYPE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CONTROLLED STUDY; FEMALE; FIBROBLAST; GINGIVA; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; PERIODONTAL DISEASE; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE HOMOGENATE; WESTERN BLOTTING; CASE CONTROL STUDY; ENZYMOLOGY; METABOLISM; PATHOLOGY; REFERENCE VALUE;

CASE-CONTROL STUDIES; GINGIVA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 14; PERIODONTITIS; REFERENCE VALUES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 77950482640     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01651.x     Document Type: Article

References (40)

1. Achong R, Nishimura I, Ramachandran H, Howell TH, Fiorellini JP, Karimbux NY (2003). Membrane type (MT)-1 matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat. J Periodontol 74 : 494 500.
2. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R (2001). Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. J Clin Periodontol 28 : 353 359.
3. Burrage PS, Mix KS, Brinckerhoff CE (2006). Matrix metalloproteinases: role in arthritis. Front Biosci 11 : 529 543.
4. Dahan M, Nawrocki B, Elkaïm R et al (2001). Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 28 : 128 136.
5. Haerian A, Adonogianaki E, Mooney J, Docherty JP, Kinane DF (1995). Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol 22 : 505 509.
6. Han Y-P, Tuan T-L, Huayang W, Hughes M, Garner WL (2001). TNF-α stimulates activation of pro-MMP2 in human skin through NF-KB mediated induction of MT1-MMP. J Cell Sci 114 : 131 139.
7. Holmbeck K, Bianco P, Caterina J et al (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99 : 81 92.
8. Ingman T, Sorsa T, Michaelis J, Konttinen YT (1994). Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 102 : 342 349.
9. Jeffrey JJ (1999). Interstitial collagenases. In : Parks WC, Mecham RP, eds Matrix metalloproteinase. 1st edn. San Diego
10. Knäuper V, Will H, López-Otin C et al (1996). Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271 : 17124 17131.
11. Kubota T, Nomura T, Takahashi T, Hara K (1996). Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 41 : 253 262.
12. Kubota T, Itagaki M, Hoshino C et al (2008). Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis- affected gingival tissue. J Periodontol 79 : 166 173.
13. Lee W, Aitken S, Sodek J, Mcculloch CAG (1995). Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 30 : 23 33.
14. Lee H, Overall CM, Mcculloch CA, Sodek J (2006). A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 17 : 4812 4826.
15. Lehti K, Lohi J, Valtanen H, Keski-Oja J (1998). Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334 : 345 353.
16. Ma J, Sorsa T, Billinghurst CR et al (2003). Direct evidence of collagenolysis in chronic periodontitis. J Periodontal Res 38 : 564 567.
17. Matías-Román S, Gálvez BG, Genís L et al (2005). Membrane-type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105 : 3956 3964.
18. Meikle MC, Hembry RM, Holley J, Horton C, Mcfarlane CG, Reynolds JJ (1994). Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodontal Res 29 : 118 126.
19. Migita K, Eguchi K, Kawabe Y et al (1996). TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89 : 553 557.
20. Orlichenko LS, Radisky DC (2008). Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis 25 : 593 600.
21. Osenkowski P, Toth M, Fridman R (2004). Processing, shedding, and endocytosis of membrane type-1 matrix metalloproteinase (MT1-MMP). J Cell Physiol 200 : 2 10.
22. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997). Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 : 14. 216-248.
23. Page-McCaw A, Ewald AJ, Werb Z (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8 : 221 233.
24. Pender SL, Salmela MT, Monteleone G et al (2000). Ligation of alpha4beta1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am J Pathol 157 : 1955 1962.
25. Pozo P, Valenzuela MA, Melej C et al (2005). Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res 40 : 199 207.
26. Raffetto JD, Khalil RA (2008). Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75 : 346 359.
27. Rossomando EF, Kennedy JE, Hadjimichael J (1990). Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 35 : 431 434.
28. Sabeh F, Ota I, Holmbeck K et al (2004). Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167 : 769 781.
29. Sato H, Takino T, Okada Y et al (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 : 61 65.
30. Silva N, Dutzan N, Hernandez M et al (2008). Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 35 : 206 214.
31. Smith PC, Guerrero J, Tobar N, Cáceres M, González MJ, Martínez J (2009). Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts. J Periodontal Res 44 : 73 80.
32. Soell M, Elkaim R, Tenenbaum H (2002). Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 81 : 174 178.
33. Sorsa T, Tjäderhane L, Konttinen YT et al (2006). Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38 : 306 321.
34. Strongin AY, Collier L, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270 : 5331 5338.
35. Tam EM, Wu YI, Butler GS, Stack MS, Overall CM (2002). Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. J Biol Chem 277 : 39005 39014.
36. Tam EM, Morrison CJ, Wu YI, Snack MS, Overall CM (2004). Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci USA 101 : 6917 6922.
37. Tervahartiala T, Pirilä E, Ceponis A et al (2000). The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 79 : 1969 1977.
38. Uitto V-J, Airola K, Vaalamo M et al (1998). Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 152 : 1489 1499.
39. Wooley DE, Davies RM (1981). Immunolocalization of collagenase in periodontal disease. J Periodontal Res 16 : 292 297.
40. Zucker S, Drews M, Conner C et al (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273 : 1216 1222.